Mirum Pharmaceuticals is trading at $82.66, up +4.30%, with the cause of the October 7 move unclear.
- No verified company announcement or other clear company-specific catalyst for the move surfaced in the search.
- Recent coverage described shares as lower amid a broad biotech pullback, which does not explain the intraday rise.
- The supplied market and biotech context is negative and also does not explain the gain.